Three new members have been appointed to the governing body of the General Pharmaceutical Council (GPhC).
The three new Council members – Rose Marie Parr, Selina Ullah and Yousaf Ahmad – will take up their positions on 01 April 2020.
The newly appointed Council members are replacing Alan Kershaw, Digby Emson OBE and Evelyn McPhail, who are standing down after serving two terms on the Council. Mr Emson will also be leaving his post as Chair of the Audit and Risk Committee.
GPhC Chair Nigel Clarke said:
“I am delighted to announce the appointments of Rose Marie, Selina and Yousaf. Each of them brings a wealth of high-level experience and expertise – they will be valuable assets to the Council.
“I’d also like to take this opportunity to thank our outgoing Council members for their dedicated service and wish them well for the future.”
Rose Marie Parr
Rose Marie Parr has been the Chief Pharmaceutical Officer for Scotland since 2015 and will be retiring from that role in July 2020. Rose Marie was previously chair of the Scottish Pharmacy Board of the Royal Pharmaceutical Society of Great Britain (RPSGB) and chair of the GPhC’s Board of Assessors, which oversees the registration assessment.
Rose Marie has also held posts in hospital pharmacy and roles at NHS Education for Scotland. Rose Marie also holds honorary professorships at both Scottish schools of pharmacy – Strathclyde University and Robert Gordon University.
Selina Ullah
Selina Ullah has over 25 years’ non-executive board experience. Selina is deputy chair and senior independent director of a large NHS hospital trust, board member of Locala Community Partnerships CIC, non-executive director of Accent Group and chair of various charities.
Selina has experience in regulation, professional standards and education, chairing board sub-committees on standards, education and workforce.
Yousaf Ahmad
Yousaf Ahmad is currently Chief Pharmacist of Care UK Healthcare group that covers primary, secondary, health in justice and residential care. Yousaf has extensive experience within secondary care, having worked primarily in large acute health boards in Scotland and in the Middle East. He has represented pharmacy at a national level through committee memberships with UKCPA and the RPS bodies.
